Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Integra Lifesciences Holdings Corp shares valued at $102,150 were purchased by GRAVES JEFFREY A on Nov 05 ’25. At $11.35 per share, GRAVES JEFFREY A acquired 9,000 shares. The insider’s holdings grew to 41,086 shares worth approximately $0.46 million following the completion of this transaction.
Also, Schwartz Eric sold 4,070 shares, netting a total of over 100,102 in proceeds. Following the sale of shares at $24.59 each, the insider now holds 59,511 shares.
Before that, Schwartz Eric had added 4,070 shares to its account. In a trade valued at $100,102, the Officer bought Integra Lifesciences Holdings Corp shares for $24.59 each.
As published in a research note from Argus on March 31, 2025, Integra Lifesciences Holdings Corp [IART] has been rated up from a Hold to a Buy. Analysts at Morgan Stanley started covering the stock with ‘”an Underweight”‘ outlook in a report released in early December. As of October 07, 2024, BTIG Research has increased its “Sell” rating to a “Neutral” for IART. Earlier on July 30, 2024, Citigroup downgraded its rating. Their new recommendation was “a Sell” for IART stock which previously was a “a Neutral”.
Analyzing IART Stock Performance
On last trading session, Integra Lifesciences Holdings Corp [NASDAQ: IART] plunged -1.58% to $11.22. The stock’s lowest price that day was $11.01, but it reached a high of $11.33 in the same session. During the last five days, there has been a drop of approximately -5.00%. Over the course of the year, Integra Lifesciences Holdings Corp shares have dropped approximately -53.48%. Shares of the company reached a 52-week high of $27.13 on 01/30/25 and a 52-week low of $10.87 on 11/05/25.
Support And Resistance Levels for Integra Lifesciences Holdings Corp (IART)
According to the 24-hour chart, there is a support level at 11.04, which, if violated, would cause prices to drop to 10.87. In the upper region, resistance lies at 11.36. The next price resistance is at 11.51. RSI (Relative Strength Index) is 30.45 on the 14-day chart, showing neutral technical sentiment.
Is Integra Lifesciences Holdings Corp subject to short interest?
Stocks of Integra Lifesciences Holdings Corp saw a sharp rise in short interest on 2025-10-15 jumping by 0.27 million shares to 6.69 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 6.42 million shares. A jump of 3.97% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.54 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.54.
Which companies own the most shares of Integra Lifesciences Holdings Corp (IART)?
In terms of Integra Lifesciences Holdings Corp share price expectations, FactSet research, analysts set an average price target of 15 in the next 12 months, up nearly 31.58% from the previous closing price of $11.4. Analysts anticipate Integra Lifesciences Holdings Corp stock to reach 15 by 2025, with the lowest price target being 15. In spite of this, 5 analysts ranked Integra Lifesciences Holdings Corp stock as Buy at the end of 2025. On July 30, 2024, BTIG Research assigned a price target of “a Sell” to the stock and downgraded coverage with a $22.
